SCHEMBL29835367

SCHEMBL29835367

Cc1ccc(S(=O)(=O)OCC2(COS(=O)(=O)c3ccc(C)cc3)CC(=O)C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VDR P11473 1/20 0.41
STAT3 P40763 1/20 0.40
GAA P10253 1/20 0.39
KMT2A Q03164 2/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA9 Q16790 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 5/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MMP2 P08253 2/20 0.38
CA2 P00918 1/20 0.37
CA3 P07451 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18047923 0.84 SMN1; SMN2 (0.46) VDRSTAT3GAAKMT2ACA12
SCHEMBL9942928 0.84 KMT2A (0.40) VDRSTAT3GAAKMT2ACA12
SCHEMBL11637311 0.81 KMT2A (0.47) VDRSTAT3GAAKMT2ACA12
SCHEMBL15979027 0.80 KMT2A (0.37) VDRSTAT3GAAKMT2ACA12
SCHEMBL690833 0.80 STAT3 (0.40) VDRSTAT3GAAKMT2ACA12
SCHEMBL7849587 0.80 KMT2A (0.50) VDRSTAT3GAAKMT2ACA12
SCHEMBL16035308 0.80 KMT2A (0.39) VDRSTAT3GAAKMT2ACA12
SCHEMBL18218 0.78 KMT2A (0.47) VDRSTAT3GAAKMT2ACA12
SCHEMBL13453046 0.78 STAT3 (0.38) VDRSTAT3GAAKMT2ACA12
SCHEMBL16835 0.78 KMT2A (0.44) VDRSTAT3GAAKMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4288426-A1 QUINOXALINE DERIVATIVES AND USES THEREOF Black Diamond Therapeutics, Inc. (US) 2023-12-13 EP disclosed
WO-2022266426-A1 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed
WO-2022266458-A1 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed
WO-2022170122-A1 QUINOXALINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed